Dynamic changes of respiratory microbiota associated with treatment outcome in drug-sensitive and drug-resistant pulmonary tuberculosis
Authors:
Open Access
- 9 September 2024
- journal article
- research article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 23 (1) , 1-10
Abstract
Respiratory microbiota is closely related to tuberculosis (TB) initiation and progression. However, the dynamic changes of respiratory microbiota during treatment and its association with TB progression remains unclear. A total of 16 healthy individuals and 16 TB patients (10 drug-sensitive TB (DS-TB) and 6 drug-resistant TB (DR-TB)) were recruited. Sputum samples were collected at baseline for all anticipants and after anti-TB treatment at Month-6 for TB patients. High throughput 16 S RNA sequencing was used to characterize the respiratory microbiota composition. Compared to the healthy individuals, TB patients exhibited lower respiratory microbiota diversity (p < 0.05). This disruption was alleviated after anti-TB treatment, especially for DS-TB patients. Parvimonas spp. numbers significantly increased after six months of anti-TB treatment in both DS-TB and DR-TB patients (p < 0.05). Rothia spp. increase during treatment was associated with longer sputum-culture conversion time and worse pulmonary lesion absorption (p < 0.05). Besides, Moraxella spp. prevalence was associated with longer sputum-culture conversion time, while Gemella spp. increase was associated with worsening resolving of pulmonary lesions (p < 0.05). Dynamic changes of respiratory microbiota during anti-TB treatment is closely related to TB progression. The involvement of critical microorganisms, such as Parvimonas spp., Rothia spp., Moraxella, and Gemella spp., appears to be associated with pulmonary inflammatory conditions, particularly among DR-TB. These microorganisms could potentially serve as biomarkers or even as targets for therapeutic intervention to enhance the prognosis of tuberculosis patients.Keywords
Funding Information
- Guangzhou Science and Technology Bureau Municipal-University(Institute) Joint Funding Project (2024A03J0585, 2024A03J0585)
- Guangdong Provincial Health Commission Funding (A2019342, A2019342)
This publication has 32 references indexed in Scilit:
- The respiratory microbiota: new insights into pulmonary tuberculosisBMC Infectious Diseases, 2019
- The Effects of Secondary Pneumonia on the Curative Efficacy of Multidrug-resistant Tuberculosis: A Retrospective Cohort Study2018
- The Microbiome and Tuberculosis: Early Evidence for Cross TalkmBio, 2018
- Predicting Tuberculosis Treatment Outcome Using MetabolomicsBiomarkers in Medicine, 2017
- Microbiome in interstitial lung diseaseCurrent Opinion in Pulmonary Medicine, 2017
- Microbiome diversity in the sputum of patients with pulmonary tuberculosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2016
- The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infectionTuberculosis, 2015
- Imaging of community-acquired pneumonia: Roles of imaging examinations, imaging diagnosis of specific pathogens and discrimination from noninfectious diseasesWorld Journal of Radiology, 2014
- Sputum Microbiota Associated with New, Recurrent and Treatment Failure TuberculosisPLOS ONE, 2013
- Sputum Microbiota in Tuberculosis as Revealed by 16S rRNA PyrosequencingPLOS ONE, 2013